Tan WSD - Search Results

1

Anti-fibrotic strategies and pulmonary fibrosis.

Gunatilaka A, Zhang S, Tan WSD, G Stewart A. Gunatilaka A, et al. Among authors: tan wsd. Adv Pharmacol. 2023;98:179-224. doi: 10.1016/bs.apha.2023.04.002. Epub 2023 Apr 27. Adv Pharmacol. 2023. PMID: 37524487

2

A Unique CD27^-IgD^- B Cell Population in the Sputum of Severe Eosinophilic Asthma Associated with Airway Autoimmunity.

Tan NS, Mukherjee M, Lim SY, Rouers A, Hwang YY, Thiam CH, Tan WSD, Liao W, Wong WSF, Liew MF, Nair P, Larbi A, Wang Y, Fink K, Angeli V, Lim HF. Tan NS, et al. Among authors: tan wsd. Am J Respir Cell Mol Biol. 2022 Oct;67(4):506-511. doi: 10.1165/rcmb.2022-0137LE. Am J Respir Cell Mol Biol. 2022. PMID: 36178857 No abstract available.

3

Polypharmacology of andrographolide: beyond one molecule one target.

Tran QTN, Tan WSD, Wong WSF, Chai CLL. Tran QTN, et al. Among authors: tan wsd. Nat Prod Rep. 2021 Apr 1;38(4):682-692. doi: 10.1039/d0np00049c. Epub 2020 Oct 6. Nat Prod Rep. 2021. PMID: 33021616

4

Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD.

Mei D, Tan WSD, Liao W, Heng CKM, Wong WSF. Mei D, et al. Among authors: tan wsd. Pharmacol Res. 2020 Nov;161:105223. doi: 10.1016/j.phrs.2020.105223. Epub 2020 Oct 2. Pharmacol Res. 2020. PMID: 33017650 Free PMC article.

5

Therapeutic RNA Strategies for Chronic Obstructive Pulmonary Disease.

Mei D, Tan WSD, Tay Y, Mukhopadhyay A, Wong WSF. Mei D, et al. Among authors: tan wsd. Trends Pharmacol Sci. 2020 Jul;41(7):475-486. doi: 10.1016/j.tips.2020.04.007. Epub 2020 May 17. Trends Pharmacol Sci. 2020. PMID: 32434654 Review.

6

Granulocyte-targeted therapies for airway diseases.

Tavares LP, Peh HY, Tan WSD, Pahima H, Maffia P, Tiligada E, Levi-Schaffer F. Tavares LP, et al. Among authors: tan wsd. Pharmacol Res. 2020 Jul;157:104881. doi: 10.1016/j.phrs.2020.104881. Epub 2020 May 4. Pharmacol Res. 2020. PMID: 32380052 Free PMC article. Review.

7

Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease.

Liao W, Lim AYH, Tan WSD, Abisheganaden J, Wong WSF. Liao W, et al. Among authors: tan wsd. Br J Pharmacol. 2020 Aug;177(16):3662-3673. doi: 10.1111/bph.15080. Epub 2020 Jun 1. Br J Pharmacol. 2020. PMID: 32335896 Free PMC article.

8

Ultrastructural Characteristics of DHA-Induced Pyroptosis.

Herr DR, Yam TYA, Tan WSD, Koh SS, Wong WSF, Ong WY, Chayaburakul K. Herr DR, et al. Among authors: tan wsd. Neuromolecular Med. 2020 Jun;22(2):293-303. doi: 10.1007/s12017-019-08586-y. Epub 2020 Jan 4. Neuromolecular Med. 2020. PMID: 31902115 Free PMC article.

9

Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD.

Mei D, Tan WSD, Wong WSF. Mei D, et al. Among authors: tan wsd. Curr Opin Pharmacol. 2019 Jun;46:73-81. doi: 10.1016/j.coph.2019.04.010. Epub 2019 May 9. Curr Opin Pharmacol. 2019. PMID: 31078066 Review.

10

Dysregulated autophagy in COPD: A pathogenic process to be deciphered.

Tan WSD, Shen HM, Wong WSF. Tan WSD, et al. Pharmacol Res. 2019 Jun;144:1-7. doi: 10.1016/j.phrs.2019.04.005. Epub 2019 Apr 3. Pharmacol Res. 2019. PMID: 30953685 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page